Statistics for Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data
Total visits
| views | |
|---|---|
| Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data | 76 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:bcdd0227-1f27-4804-8d01-75ea0b67f0be | 56 |
| Limdi2020Cost-NIHAAM.pdf | 52 |
| java.util.UUID:70272713-bfb8-4d88-a1b1-412c5d6e624c | 14 |
| java.util.UUID:34b5586e-8221-4849-aaea-a766c4270965 | 5 |
Top country views
| views | |
|---|---|
| United States | 68 |
| India | 2 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Fairfield | 11 |
| Baltimore | 5 |
| Houston | 5 |
| White Plains | 2 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Hyderabad | 1 |
| Kuala Lumpur | 1 |
| New York | 1 |
| Pune | 1 |